Intended for healthcare professionals


FDA unexpectedly rescinds ban on Juul vapes

BMJ 2024; 385 doi: (Published 10 June 2024) Cite this as: BMJ 2024;385:q1282
  1. Owen Dyer
  1. Montreal

The US Food and Drug Administration (FDA) has dropped marketing denial orders which sought to ban the entire range of Juul Laboratories’ vaping products from being sold in the US. The surprise decision came as a shock to anti-smoking campaigners, as the FDA has repeatedly singled out Juul’s products as prime drivers of a surge in youth vaping.

In announcing the decision the FDA pointed to “new litigation outcomes in cases about marketing denial orders for e-cigarette products from other manufacturers,” some of which “establish new case law and inform the FDA’s approach to product review.”1

But the agency also said that in the time since the ban was imposed in June 2022 it “has gained more experience with various scientific matters regarding e-cigarette products,” and has “conducted an additional substantive review of the applications in a number of disciplines, including toxicology, engineering, social …

View Full Text

Log in

Log in through your institution


* For online subscription